Evidence map›Paper›PMID 27734911›Full record

ArticleScientific reports2016

Novelty during a late postacquisition time window attenuates the persistence of fear memory.

Cynthia Katche, Micol Tomaiuolo, Guido Dorman, Jorge H Medina, Haydee Viola

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cynthia KatcheInstituto de Biología Celular y Neurociencias, Facultad de Medicina "Dr Eduardo De Robertis" (UBA-CONICET), UBA, Paraguay 2155, 3 piso, Buenos Aires (C1121ABG), Argentina.
Micol TomaiuoloInstituto de Biología Celular y Neurociencias, Facultad de Medicina "Dr Eduardo De Robertis" (UBA-CONICET), UBA, Paraguay 2155, 3 piso, Buenos Aires (C1121ABG), Argentina.
Guido DormanInstituto de Biología Celular y Neurociencias, Facultad de Medicina "Dr Eduardo De Robertis" (UBA-CONICET), UBA, Paraguay 2155, 3 piso, Buenos Aires (C1121ABG), Argentina.
Jorge H MedinaInstituto de Biología Celular y Neurociencias, Facultad de Medicina "Dr Eduardo De Robertis" (UBA-CONICET), UBA, Paraguay 2155, 3 piso, Buenos Aires (C1121ABG), Argentina.
Haydee ViolaInstituto de Biología Celular y Neurociencias, Facultad de Medicina "Dr Eduardo De Robertis" (UBA-CONICET), UBA, Paraguay 2155, 3 piso, Buenos Aires (C1121ABG), Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Learning to avoid threats in the environment is highly adaptive. However, sometimes a dysregulation of fear memories processing may underlie fear-related disorders. Despite recent advances, a major question of how to effectively attenuate persistent fear memories in a safe manner remains unresolved. Here we show experiments employing a behavioural tool to target a specific time window after training to limit the persistence of a fear memory in rats. We observed that exposure to a novel environment 11 h after an inhibitory avoidance (IA) training that induces a long-lasting memory, attenuates the durability of IA memory but not its formation. This effect is time-restricted and not seen when the environment is familiar. In addition, novelty-induced attenuation of IA memory durability is prevented by the intrahippocampal infusion of the CaMKs inhibitor KN-93. This new behavioural approach which targets a specific time window during late memory consolidation, might represent a new tool for reducing the durability of persistent fear memories.

Indexed as

FearMemoryAnimalsAvoidance LearningMaleRatsRats, Wistar

Identifiers

PMID27734911
PMCPMC5062250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.